R&D Innovation

Hubei Hongyuan Pharmaceutical Technology Co., Ltd

R&D Innovation

We offer chemical synthesis and discovery support, grounded in rigorous scientific practice.

This entity is recognized as a high-tech institution, an innovative organization of Hubei Province, and an Hubei Provincial Organization with Intellectual Property Advantages (Patent Category). It keeps close academic communication and solid R&D partnerships with renowned universities including Fudan University, Wuhan University, Sichuan University, Wuhan Institute of Technology and Hubei University of Chinese Medicine. To support such collaborative research, the group has built a provincial-level technical center, the Hubei Fluorine Chemical Engineering Technology Research Center, as well as a Wuhan R&D hub, establishing a well-rounded technological innovation framework.

Phase I
Molecular Synthesis

High-precision refinement of industrial precursor structures.

Phase II
Process Optimization

Scaling discovery-based manufacturing for global supply chains.

Phase III
Technical Validation

Rigorous purity verification under internationally recognized protocols.

Industrial R&D Excellence

Analytical Purity

Tier-1 molecular screening for specialized industrial consistency.

Custom Catalysts

Developing bespoke chemical solutions for niche manufacturing applications.

Safety Protocols

Integrated risk mitigation strategies in high-precision factory lines.

Global Logistics

Strategic supply chain alignment for reliable chemical fulfillment.

There are a number of independent intellectual property rights in raw materials and pharmaceutical intermediates, pharmaceutical preparations, new energy materials, etc., with 65 patents, including 57 invention patents, and innovative processes have won provincial scientific and technological progress awards for many times.